Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Parkinson Disease Topic Center

Featured Article

News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
Researchers Use AI to Predict Parkinson Disease Up to 7 Years
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care
News
Investigational PD Cell Therapy Receives FDA RMAT Designation
06/06/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care
News
Exposure to Airborne Manganese, Beryllium, and Nickel May Increase the Risk of Parkinson Disease
05/21/2024
Lisa Kuhns, PhD
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to...
05/21/2024
Annals of Long-Term Care
News
Neurostimulation Produces a Stable Quality of Life Up to 5 Years in Patients With Parkinson Disease, Study Finds
05/08/2024
Lisa Kuhns, PhD
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the...
05/08/2024
Annals of Long-Term Care
News
Improving Patient Engagement in Value-Based Care
04/09/2024

Emry Lloyd

Emry Lloyd
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients...
04/09/2024
Annals of Long-Term Care
News
Skin Biopsies Show Promise as Diagnostic Tool for Synucleinopathies Such as Parkinson Disease
04/04/2024
Hannah Musick
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise...
04/04/2024
Annals of Long-Term Care
News
Guidance Aims to Protect PD Patients from Harm During Hospitalization
03/19/2024
Jolynn Tumolo
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the...
03/19/2024
Annals of Long-Term Care
News
Utilizing Gold Nanoparticles in Therapy for Patients With Parkinson Disease
03/05/2024

Emry Lloyd

Emry Lloyd
Researchers discover various uses of green synthesis for patients with Parkinson disease and the benefits of this nanoparticle synthesis with gold.
Researchers discover various uses of green synthesis for patients with Parkinson disease and the benefits of this nanoparticle synthesis with gold.
Researchers discover various...
03/05/2024
Annals of Long-Term Care
News
False Claims Act Allegations Peak in 2023
02/29/2024

By Emry Lloyd

By Emry Lloyd
Last year, health care providers paid the federal government over $2.7 billion because of false claims. What does this mean for health care providers and skilled nurses in 2024?
Last year, health care providers paid the federal government over $2.7 billion because of false claims. What does this mean for health care providers and skilled nurses in 2024?
Last year, health care providers...
02/29/2024
Annals of Long-Term Care

Newsfeed

News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
Researchers Use AI to Predict Parkinson Disease Up to 7 Years
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care
News
Investigational PD Cell Therapy Receives FDA RMAT Designation
06/06/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care
News
Exposure to Airborne Manganese, Beryllium, and Nickel May Increase the Risk of Parkinson Disease
05/21/2024
Lisa Kuhns, PhD
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to...
05/21/2024
Annals of Long-Term Care
News
Neurostimulation Produces a Stable Quality of Life Up to 5 Years in Patients With Parkinson Disease, Study Finds
05/08/2024
Lisa Kuhns, PhD
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the...
05/08/2024
Annals of Long-Term Care
News
Improving Patient Engagement in Value-Based Care
04/09/2024

Emry Lloyd

Emry Lloyd
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients engage in health care and receive care. Physicians and providers need to discover new and engaging ways to get patients more involved in value-based care.
Apathy can affect how patients...
04/09/2024
Annals of Long-Term Care
News
Skin Biopsies Show Promise as Diagnostic Tool for Synucleinopathies Such as Parkinson Disease
04/04/2024
Hannah Musick
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise as a diagnostic tool for synucleinopathies like Parkinson disease, with high rates of phosphorylated α-synuclein detected in affected individuals compared to controls.
Skin biopsies may hold promise...
04/04/2024
Annals of Long-Term Care
News
Guidance Aims to Protect PD Patients from Harm During Hospitalization
03/19/2024
Jolynn Tumolo
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the hospitalization experience of patients with Parkinson disease (PD), released last year by the Parkinson’s Foundation, aim to ease the increased risk of preventable harm for the hundreds of thousands of people...
Recommendations to improve the...
03/19/2024
Annals of Long-Term Care
News
Utilizing Gold Nanoparticles in Therapy for Patients With Parkinson Disease
03/05/2024

Emry Lloyd

Emry Lloyd
Researchers discover various uses of green synthesis for patients with Parkinson disease and the benefits of this nanoparticle synthesis with gold.
Researchers discover various uses of green synthesis for patients with Parkinson disease and the benefits of this nanoparticle synthesis with gold.
Researchers discover various...
03/05/2024
Annals of Long-Term Care
News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
Acupuncture May Enhance Sleep Quality in Patients With Parkinson Disease
07/18/2024
“In this randomized clinical trial, acupuncture improved sleep quality and overall quality of life for individuals with PD. The therapeutic effects persisted for up to 4 weeks, underscoring the potential of acupuncture as a beneficial adjunct...
“In this randomized clinical trial, acupuncture improved sleep quality and overall quality of life for individuals with PD. The therapeutic effects persisted for up to 4 weeks, underscoring the potential of acupuncture as a beneficial adjunct...
“In this randomized clinical...
07/18/2024
Annals of Long-Term Care
News
Researchers Use AI to Predict Parkinson Disease Up to 7 Years
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care
News
Investigational PD Cell Therapy Receives FDA RMAT Designation
06/06/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care
News
SNF Residents Sue Maryland Health Department for Failing to Conduct Inspections
05/29/2024
Jolynn Tumolo
A group of nursing home residents in Maryland filed a class action lawsuit against the state health department for failing to meet requirements calling for annual inspections of skilled nursing facilities (SNFs), McKnights Long-Term Care News...
A group of nursing home residents in Maryland filed a class action lawsuit against the state health department for failing to meet requirements calling for annual inspections of skilled nursing facilities (SNFs), McKnights Long-Term Care News...
A group of nursing home...
05/29/2024
Annals of Long-Term Care
News
More State Policies Not Always Linked With Less COVID-19 Burden in Nursing Homes
05/22/2024
Jolynn Tumolo
Higher numbers of pandemic policies at the state and territory levels were not consistently associated with fewer COVID-19 cases and deaths in nursing homes or in the community, according to a study published in a research letter in JAMA...
Higher numbers of pandemic policies at the state and territory levels were not consistently associated with fewer COVID-19 cases and deaths in nursing homes or in the community, according to a study published in a research letter in JAMA...
Higher numbers of pandemic...
05/22/2024
Annals of Long-Term Care
News
Exposure to Airborne Manganese, Beryllium, and Nickel May Increase the Risk of Parkinson Disease
05/21/2024
Lisa Kuhns, PhD
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to...
05/21/2024
Annals of Long-Term Care
News
New Rules Address Minimum LTC Staffing, Home Care Worker Wages
05/15/2024
Jolynn Tumolo
Vice President Kamala Harris announced 2 final rules last month that aim to improve long-term care and home care services.
Vice President Kamala Harris announced 2 final rules last month that aim to improve long-term care and home care services.
Vice President Kamala Harris...
05/15/2024
Annals of Long-Term Care
News
Neurostimulation Produces a Stable Quality of Life Up to 5 Years in Patients With Parkinson Disease, Study Finds
05/08/2024
Lisa Kuhns, PhD
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Deep brain stimulation of the...
05/08/2024
Annals of Long-Term Care

Advertisement

Insights

Headshot of Dr Ruth Schneider on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Treatment Efficacy for Parkinson Disease-Related Anxiety
06/29/2021
Julie Gould
Maria Asimopoulos
Ruth Schneider, MD, assistant professor and director, Huntington’s Disease Society of America Center of Excellence, University of Rochester, discusses her recent research that examined patient outcomes and responses to buspirone in the...
Ruth Schneider, MD, assistant professor and director, Huntington’s Disease Society of America Center of Excellence, University of Rochester, discusses her recent research that examined patient outcomes and responses to buspirone in the...
Ruth Schneider, MD, assistant...
06/29/2021
Annals of Long-Term Care
Beneficial Treatments for OFF Episodes Among Patients With PD
Videos
Beneficial Treatments for OFF Episodes Among Patients With PD
02/18/2021
Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for OFF episodes...
Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for OFF episodes...
Maria C Ospina, MD, movement...
02/18/2021
Annals of Long-Term Care
Parkinson Disease: Therapeutic Interventions and How Care Has Changed Since COVID First Struck
Videos
Parkinson Disease: Therapeutic Interventions and How Care Has Changed Since COVID First Struck
11/17/2020
Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate...
Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate...
Luca Marsili MD, PhD, Gardner...
11/17/2020
Annals of Long-Term Care
Interview
A Potential Blood Test for Parkinson Disease
05/14/2019
Despite Parkinson disease diagnosis challenges, new research shines light on a potential noninvasive diagnostic test. Professor of neurology at the Brain Research Institute Gal Bitan, PhD, discusses his recent study findings.
Despite Parkinson disease diagnosis challenges, new research shines light on a potential noninvasive diagnostic test. Professor of neurology at the Brain Research Institute Gal Bitan, PhD, discusses his recent study findings.
Despite Parkinson disease...
05/14/2019
Annals of Long-Term Care
Interview
Determining Appropriate Time to Initiate PD Treatment
03/12/2019
Rob di Bie, MD, PhD, neurologist and professor of Movement Disorders at the University of Amsterdam’s Faculty of Medicine, discusses the long-term effects of a specific PD medication and the impact of starting the drug early.
Rob di Bie, MD, PhD, neurologist and professor of Movement Disorders at the University of Amsterdam’s Faculty of Medicine, discusses the long-term effects of a specific PD medication and the impact of starting the drug early.
Rob di Bie, MD, PhD, neurologist...
03/12/2019
Annals of Long-Term Care
Podcasts
Is it Safe to Treat PD With a Drug Approved for Psuedobulbar Affect?
02/21/2019
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why...
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why...
Michael Fralick, MD, FRCPC,...
02/21/2019
Annals of Long-Term Care

Advertisement

Annals of Long-Term Care Newsletter

Advertisement

Recent Content

News
PD-Related Genes Contribute to Disease in 15% of Patients
08/05/2024
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
MRI-Guided Focused Ultrasound Subthalamotomy for Treating Parkinson Disease
07/23/2024
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
Researchers Use AI to Predict Parkinson Disease Up to 7 Years
06/20/2024
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care
News
Investigational PD Cell Therapy Receives FDA RMAT Designation
06/06/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care
News
Exposure to Airborne Manganese, Beryllium, and Nickel May Increase the Risk of Parkinson Disease
05/21/2024
Lisa Kuhns, PhD
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to airborne manganese, beryllium, and nickel may increase the risk of Parkinson disease (PD), according to study results presented at the 2024 Annual Meeting of the American Academy of Neurology.
Environmental exposure to...
05/21/2024
Annals of Long-Term Care

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement